Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
10,991,993
-
Share change
-
-292,934
-
Total reported value
-
$102,314,000
-
Price per share
-
$9.31
-
Number of holders
-
15
-
Value change
-
-$2,765,543
-
Number of buys
-
3
-
Number of sells
-
9
Institutional Holders of AC Immune SA - SHS (ACIU) as of Q2 2018
As of 30 Jun 2018,
AC Immune SA - SHS (ACIU) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,991,993 shares.
The largest 10 holders included
FMR LLC, Duquesne Family Office LLC, Temasek Holdings (Private) Ltd, FIL Ltd, PointState Capital LP, Artal Group S.A., Tekla Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, and Balyasny Asset Management LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.